Zimmer Biomet Holdings
Stock Forecast, Prediction & Price Target
Zimmer Biomet Holdings Financial Estimates
Zimmer Biomet Holdings Revenue Estimates
Zimmer Biomet Holdings EBITDA Estimates
Zimmer Biomet Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $6.82B N/A | $6.93B 1.64% | $7.39B 6.54% | Avg: $8.11B Low: $8.06B High: $8.17B avg. 9.79% | Avg: $8.45B Low: $8.37B High: $8.51B avg. 4.19% | Avg: $8.99B Low: $8.90B High: $9.04B avg. 6.29% | Avg: $9.33B Low: $9.25B High: $9.39B avg. 3.86% |
Net Income
% change YoY
| $401.6M N/A | $231.4M -42.38% | $1.02B 342.52% | Avg: $1.19B Low: $891.22M High: $1.40B avg. 17.04% | Avg: $1.34B Low: $1.25B High: $1.53B avg. 11.86% | Avg: $2.12B Low: $2.10B High: $2.14B avg. 58.85% | Avg: $2.23B Low: $2.21B High: $2.25B avg. 5.05% |
EBITDA
% change YoY
| $1.95B N/A | $1.99B 1.80% | $2.21B 11.24% | Avg: $2.31B Low: $2.29B High: $2.32B avg. 4.41% | Avg: $2.40B Low: $2.38B High: $2.42B avg. 4.19% | Avg: $2.56B Low: $2.53B High: $2.57B avg. 6.29% | Avg: $2.65B Low: $2.63B High: $2.67B avg. 3.86% |
EPS
% change YoY
| $1.93 N/A | $1.39 -27.97% | $4.91 253.23% | Avg: $5.66 Low: $4.25 High: $6.68 avg. 15.29% | Avg: $6.54 Low: $5.99 High: $7.32 avg. 15.55% | Avg: $10.16 Low: $10.03 High: $10.24 avg. 55.26% | Avg: $10.67 Low: $10.54 High: $10.76 avg. 5.05% |
Operating Expenses
% change YoY
| $3.86B N/A | $3.72B -3.44% | $4.03B 8.16% | Avg: $3.35B Low: $3.33B High: $3.38B avg. -16.78% | Avg: $3.49B Low: $3.46B High: $3.51B avg. 4.19% | Avg: $3.71B Low: $3.68B High: $3.74B avg. 6.29% | Avg: $3.86B Low: $3.82B High: $3.88B avg. 3.86% |
FAQ
What is Zimmer Biomet Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 23.20% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is 891.22M, average is 1.19B and high is 1.40B.
What is Zimmer Biomet Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6.03% in 2025-2028.
We have gathered data from 21 analysts. Their low revenue estimate is $8.06B, average is $8.11B and high is $8.17B.
What is Zimmer Biomet Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.79% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is $4.25, average is $5.66 and high is $6.68.
What is the best performing analyst?
In the last twelve months analysts have been covering Zimmer Biomet Holdings stock. The most successful analyst is Richard Newitter.